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Attikon University Hospital of Athens, Athens, Greece.BACKGROUND In experimental models, stellate ganglion block
(SGB) reduces the induction of atrial ﬁbrillation (AF), while data in
humans are limited.
OBJECTIVE The aim of this study was to assess the effect of
unilateral SGB on atrial electrophysiological properties and AF
induction in patients with paroxysmal AF.
METHODS Thirty-six patients with paroxysmal AF were randomized
in a 2:1 order to temporary, transcutaneous, pharmaceutical SGB with
lidocaine or placebo before pulmonary vein isolation. Lidocaine was
1:1 randomly infused to the right or left ganglion. Before and after
randomization, atrial effective refractory period (ERP) of each atrium,
difference between right and left atrial ERP, intra- and interatrial
conduction time, AF inducibility, and AF duration were assessed.
RESULTS After SGB, right atrial ERP was prolonged from a median
(1st-3rd quartile) of 240 (220–268) ms to 260 (240–300) ms
(P o .01) and left atrial ERP from 235 (220–260) ms to 245
(240–280) ms (P o .01). AF was induced by atrial pacing in allOpen access publication of this article is supported by an unrestricted
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CC BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0/24 patients before SGB, but only in 13 patients (54%) after the
intervention (P o .01). AF duration was shorter after SGB: 1.5
(0.0–5.8) minutes from 5.5 (3.0–12.0) minutes (P o .01). Intra-
and interatrial conduction time was not signiﬁcantly prolonged. No
signiﬁcant differences were observed between right and left SGB.
No changes were observed in the placebo group.
CONCLUSION Unilateral temporary SGB prolonged atrial ERP,
reduced AF inducibility, and decreased AF duration. An equivalent
effect of right and left SGB on both atria was observed. These ﬁndings
may have a clinical implication in the prevention of drug refractory
and postsurgery AF and deserve further clinical investigation.
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Paroxysmal atrial tachycardia or atrial ﬁbrillation (AF) in
animal models are preceded by increased extrinsic cardiac
nerve activity recorded in left stellate ganglion.1 Additional
experimental studies suggest that stimulation of the stellate
ganglion increases sinus rate and predisposes to atrial
arrhythmias.2,3 While unilateral electrical stimulation of the
stellate ganglion facilitates the induction of AF andaggravates atrial electrical remodeling in canine models,
unilateral ganglionectomy reduces AF induction.4
In humans, unilateral right stellate ganglion block (SGB)
has a combined sympathetic and parasympathetic inﬂuence
on sinus node, resulting in a decrease in sinus rate.5,6 After
SGB, a decrease in low frequency and low/high frequency
ratio of heart rate variability has been observed, suggesting a
shift in cardiac autonomic balance toward the predominance
of parasympathetic over sympathetic activity.7 Although left
SGB has been proposed as an effective treatment for drug
refractory ventricular tachycardia or ﬁbrillation, the effect of
this technique on atrial arrhythmias has not been extensively
studied.8,9
The aim of the present randomized, placebo-controlled
study was to assess the acute impact of unilateral SGB on
human atrial electrophysiological properties and AFbehalf of Heart Rhythm Society. This is an Open access article under
http://dx.doi.org/10.1016/j.hrthm.2016.06.025
Figure 1 Right and left effective refractory period (RAERP and LAERP) before and after stellate ganglion block (SGB). During pacing at 600-ms cycle length
from the high right atrium, RAERP was prolonged from 200 ms before (A) to 240 ms after (B) block. Similarly, LAERP was 220 ms before (C) and 280 ms after
(D) SGB during pacing from the distal coronary sinus. Electrocardiographic leads II, aVR, V1, V2, and V5, along with electrograms from the high right atrium
distal (HRAd) and proximal (HRAp), His area distal to proximal (Hisd, His2, His3, His4, Hisp), coronary sinus distal to proximal (CSd, CS2, CS3, CS4, CSp), and
right ventricular apex distal (RVAd) and proximal (RVAp), are presented.
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SGB, in patients with paroxysmal AF.Methods
Patients and randomization
Thirty-six consecutive patients with paroxysmal AF admit-
ted for electrical pulmonary vein isolation (PVI) were
included in the study. Antiarrhythmic drug, except amiodar-
one, was interrupted 1 week before admission. Patients with
coronary artery disease, cardiac valve dysfunction, or other
systematic disease such as diabetes mellitus, renal or hepatic
failure, and neurological diseases were excluded.
Before PVI ablation, all patients were randomized in a 2:1
order to temporary, transcutaneous, pharmaceutical SBG or
placebo treatment. In patients randomized to SBG, either the
left or the right stellate ganglion was blocked in a 1:1
sequence with paratracheal infusion of 8 mL of 1% lidocaine
solution. The efﬁcacy of SBG was conﬁrmed by the transient
appearance of Horner sign, tearing, hoarse voice, difﬁculty in
swallowing, or warmth of the ipsilateral upper extremity. In
the arm of placebo (controls), 8 mL of sodium chloride 0.9%
was paratracheally injected with the same technique.Electrophysiological parameters
After local anesthesia, quadripolar diagnostic catheters were
percutaneously advanced to the high right atrium (HRA) and at
the His bundle area so as to record upper lateral and anteroseptal
atrial electrograms, along with His electrogram. A decapolar
catheter was inserted into the coronary sinus (CS) so that the
distal bipole reached the left atrial appendage area and could
provide stable left atrial pacing, while the proximal bipole was
located at the entrance of CS. Before sedation for the transeptal
puncture and ablation procedure, the following parameters were
assessed by programmed atrial pacing: (1) right atrial effective
refractory period (RAERP) at a paced cycle length of 600 ms,deﬁned as the longest coupling interval that failed to propagate
to the atrium; (2) left atrial effective refractory period (LAERP)
at the same paced cycle length; (3) difference between RAERP
and LAERP (dERP); (4) right intra-atrial conduction time by
pacing from the distal bipole of the HRA catheter and measured
from the onset of the local atrial electrogram to the onset of the
atrial electrogram at the His area; (5) left intra-atrial conduction
time by pacing from the proximal bipole of the CS catheter and
measured from the onset of the local atrial electrogram at the
entrance of CS to the onset of the atrial electrogram at the distal
bipole; (6) right to left interatrial conduction time (IACTR-L) by
pacing from the distal bipole of the HRA catheter and measured
from the onset of the local atrial electrogram to the onset of the
distal CS electrogram; and (7) left to right interatrial conduction
time (IACTL-R) by pacing from the distal bipole of the CS
catheter and measured from the onset of the local atrial
electrogram to the onset of the distal HRA electrogram
(Figures 1 and 2). All measurements were performed at a
paced cycle length of 600 ms in order to achieve stable atrial
capture and avoid inhibition because of intrinsic extrasystoles.
After these measurements, AF induction was attempted
by pacing from the distal CS or the HRA in 15 seconds
lasting atrial bursts at a ﬁxed cycle length of 200 ms or by
decremental pacing starting at 200 ms and decrementing by
10 ms with a 10-second interval before each decrement to the
shortest cycle length that resulted in 1:1 atrial capture or until
AF was induced (Figure 3). Episodes of AF longer than 10
seconds were included in the analysis, and the duration of
arrhythmia was assessed. Episodes lasting more than 20
minutes were terminated by cardioversion.
After SGB, all the aforementioned parameters and AF
inducibility were reassessed and compared to initial ones. The
physician who performed the measurements was not aware of
which group each patient belonged to. Before enrollment, all
patients gave their informed consent and the protocol of the
study was approved by the hospital ethics committee.
Figure 2 Conduction time measurements. Right intra-atrial conduction time (A), left intra-atrial conduction time (B), right interatrial conduction time (C), and
left interatrial conduction time (D) are measured as described in the text. Abbreviations as in Figure 1.
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Continuous variables are summarized as median (1st-3rd
quartile) and compared using nonparametric tests (Wilcoxon
rank sum test or Mann-Whitney U test, as appropriate).
Categorical variables are reported as counts and percentages
and compared using the Fisher exact test. A P value ofo.05
was considered as indicative of statistical signiﬁcance.
Results
No signiﬁcant difference in baseline characteristics was
observed between patients who underwent SGB and controls
(Table 1). After SGB, a signiﬁcant increase in RAERP from
a median value of 240 ms to 260 ms and LAERP from 235
ms median to 245 ms was observed (Figure 4), while dERP
remained unaltered (Table 2). Right intra-atrial conduction
time, left intra-atrial conduction time, IACTR-L, and IACTL-R
were not signiﬁcantly prolonged, although prolongation in
IACTR-L and IACTL-R showed a tendency toward a marginal
statistical signiﬁcance (P ¼ .08 and P ¼ .07). No changes in
the aforementioned parameters were observed in the control
group. Before randomization, AF was inducible in all
patients. In the SGB group, AF inducibility was decreased
to half of the patients after SGB. In those with still inducible
AF, the mean duration of the arrhythmia was reduced to
almost half of the time before SGB, as shown in Table 2. No
signiﬁcant correlation between effective refractory period
(ERP) prolongation and AF inducibility after SGB was
documented for either atrium (P ¼ .87 for left atrial ERP
prolongation and P ¼ .57 for right atrial ERP prolongation).Similarly, induced AF duration was not associated with left
or right atrial ERP prolongation (P ¼ .73 and P ¼ .37,
respectively). In controls, AF remained inducible in all
patients after the injection of placebo, and the mean time
in arrhythmia remained unchanged.
In patients who underwent SGB, the effect of right and
left SGB was equivalent and the impact on each atrium was
comparable regardless of the site of block (Table 3). No
signiﬁcant changes in heart rate were observed after right- or
left-sided SGB.
Discussion
The effect of SGB on human atria has not been adequately
studied. This study contributes to the elucidation of this ﬁeld
with the following ﬁndings: (1) unilateral temporary trans-
cutaneous SGB was followed by a prolongation in the ERP
of both atria; (2) this effect was associated with the
prevention of AF induction in approximately half of the
studied patients and the shortening of AF duration in those
who were still prone to the arrhythmia; and (3) the beneﬁcial
impact of SGB was equivalent on both atria regardless the
site of block.
Atrial ERP
Short atrial ERP has been recognized as a factor that
predisposes to AF.10–12 On the contrary, sinus rhythm
restoration and the reversal in AF-induced atrial remodeling
are associated with ERP prolongation to normal.13,14 In
canine models, Zhou et al4 have reported that unilateral
Figure 3 Atrial ﬁbrillation (AF) inducibility before and after stellate ganglion block (SGB). Initially, AF was induced with rapid atrial pacing at 200-ms cycle
length (A). After SBG, AF was not inducible with the same pacing protocol (B). Abbreviations as in Figure 1.
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signiﬁcant shortening of atrial ERP, increase in ERP
dispersion (dERP), and facilitation of AF induction while
unilateral ganglionectomy reverses these effects. These
effects of stellate stimulation and ganglionectomy were
observed in the ipsilateral atrium.
However, there are other experimental studies suggesting
an overlap between right and left stellate ganglion activity
expressed in cardiac systolic performance and dispersion of
depolarization.15,16 In a study by Tan et al,2 there was no
signiﬁcant functional asymmetry in the hemodynamic effects
of right and left stellate stimulation at high stimulation
strengths and there was also no difference between theTable 1 Baseline characteristics of the patients randomized to
SGB and controls
Characteristic
SGB group
(n ¼ 24)
Control group
(n ¼ 12) P
Age (y) 63 (50–68) 61 (52–69) .96
Sex: male 13 (54) 7 (58) 1.00
History of AF (mo) 35 (27–46) 36 (17–46) .75
Antiarrhythmic drugs
β-Blocker 17 (70) 9 (75) 1.00
Amiodarone 7 (29) 3 (25) 1.00
Propafenone/ﬂecainide 10 (42) 4 (33) .73
Sotalol 5 (20) 3 (25) 1.00
LA diameter (mm) 47 (45–50) 47 (45–50) .99
RAERP (ms) 240 (220–268) 240 (220–260) .99
LAERP (ms) 235 (220–260) 240 (205–248) .73
Values are presented as median (1st–3rd quartile) or as n (%).
AF ¼ atrial ﬁbrillation; LA ¼ left atrial; LAERP ¼ left atrial effective
refractory period; RAERP ¼ right atrial effective refractory period;
SGB ¼ stellate ganglion block.arrhythmogenic potential of left and right stellate stimula-
tion. The authors proposed as a potential explanation for this
observation that, at higher stimulation levels, stimulation of 1
stellate ganglion may activate both ganglia.
To our knowledge, this is the ﬁrst clinical study that
observed a beneﬁcial effect of unilateral SGB, expressed by
the prolongation of ERP without dERP impairment and the
protection against AF induction, in both atria, regardless of
the site of stellate block. This may imply that there is not a
discrete ipsilateral distribution of cardiac projections of theFigure 4 Box plot graph of right (RAERP) and left (LAERP) atrial
effective refractory periods before (pre) and after (post) stellate ganglion
block (SGB). The thick horizontal black line corresponds to the median, the
box to the interquartile range, and the whiskers to the range of observed
values.
Table 2 Atrial electrophysiological properties, AF inducibility expressed as percentage of patients, and AF duration before (pre) and after
(post) intervention are presented in patients who underwent SGB and in controls
Variable
SGB group Control group
Pre Post P Pre Post P
HR (beats/min) 69.5 (66.3–80.8) 70.0 (65.0–79.5) .19 69.5 (66.3–74.8) 70.0 (66.0–74.8) .68
RAERP (ms) 240 (220–268) 260 (240–300) o.01 240 (220–260) 240 (230–257) .25
LAERP (ms) 235 (220–260) 245 (240–280) o.01 240 (205–248) 235 (203–250) .86
dERP (ms) 15 (0–20) 10 (3–20) .46 10 (10–20) 10 (0–35) .67
RICT (ms) 41 (37–47) 42 (39–46) .20 39 (35–44) 39 (35–43) .66
LICT (ms) 45 (38–54) 46 (39–53) .28 45 (38–54) 46 (39–50) .62
IACTR-L (ms) 85 (79–92) 87 (80–100) .08 85 (74–101) 92 (69–104) .78
IACTL-R (ms) 83 (70–87) 83 (73–90) .07 84 (71–87) 83 (70–88) .84
AF induction 24/24 (100) 13/24 (54) o.01 12/12 (100) 12/12 (100) 1.00
AF duration (min) 5.5 (3.0–12.0) 1.5 (0.0–5.8) o.01 5.5 (4.0–10.0) 5.5 (3.3–10.8) .82
Values are presented as median (1st–3rd quartile) or as n (%).
AF¼ atrial ﬁbrillation; dERP¼ difference between right atrial effective refractory period and left atrial effective refractory period; HR¼ heart rate; IACTL-R¼
left to right interatrial conduction time; IACTR-L¼ right to left interatrial conduction time; LAERP¼ left atrial effective refractory period; LICT¼ left intra-atrial
conduction time; RAERP ¼ right atrial effective refractory period; RICT ¼ right intra-atrial conduction time; SGB ¼ stellate ganglion block.
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extrinsic neural projections—a common intrinsic cardiac
nerve activity might be an important invariable trigger of AF,
as suggested by experimental studies.4 Furthermore, com-
mon neural autonomic pathways via right vagal projections
and superior left ganglionated plexi may explain the equiv-
alent effect of right and left SGB.17,18
Atrial and interatrial conduction time
The presence of regions with slowed conduction, facilitating
the functional substrate for the occurrence of reentry circuits
within the atria has been described as a mechanism of AF
establishment.19 Abnormalities in atrial conduction, predis-
posing to AF, have been associated with atrial dilation,
stretch, and ﬁbrosis.20 However, the inﬂuence of autonomic
modulation on atrial conduction properties in patients with
paroxysmal AF is not well known. In patients with parox-
ysmal AF undergoing ablation, complex fractionated atrial
electrograms, representing slow conduction areas, have been
attributed to parasympathetic activity, expressed via local
effects of acetylcholine on atrial tissue.21,22 In another
clinical study with 16 patients, acute vagal maneuvers wereTable 3 Comparison between right and left SGB
Variable
Right SGB
Pre Post
HR (beats/min) 71.0 (67.3–81.8) 72.0 (65.3–79.5)
RAERP (ms) 235 (205–255) 260 (240–295)
LAERP (ms) 225 (220–255) 240 (240–280)
dERP (ms) 15 (3–20) 10 (10–20)
RICT (ms) 42 (37–47) 42 (39–46)
LICT (ms) 44 (34–57) 47 (35–53)
IACTR-L (ms) 83 (76–93) 85 (74–100)
IACTL-R (ms) 81 (70–89) 84 (71–89)
AF induction 12/12 (100) 7/12 (58)
AF duration (min) 6.5 (3.0–12.8) 1.5 (0.0–5.8)
Values are presented as median (1st–3rd quartile) or as n (%).
Abbreviations as in Table 2.associated with prolonged intra-atrial conduction time and,
also, IACTR-L.
23
In our study, intra-atrial conduction time was not signiﬁ-
cantly changed after SGB. Interatrial conduction was meas-
ured not only from the right to the left atrium but also from
the left to the right atrium, since abnormalities in left to right
conduction may be related to AF induction from arrhythmo-
genic foci in the pulmonary veins.24 In both directions, we
did not observe a signiﬁcant change in interatrial conduction
time. Since prolonged conduction time is associated with an
increased propensity for AF, our ﬁndings support the
antiarrhythmic role of SGB. The borderline increase in
IACTR-L and IACTL-R is concordant with the hypothesis
that SGB is associated with the inhibition of sympathetic
nerve activation and vagal stimulation that reduces suscept-
ibility to AF.17,18,25,26 Probably, statistical signiﬁcance was
not reached because of the relatively weak vagal stimulation
that unilateral SGB exerts.
AF inducibility
Unilateral right or left stellate ganglion stimulation in
vivo is associated with increased levels of transcardiacLeft SGB
P Pre Post P
.25 68.5 (66.0–78.3) 68.0 (65.0–78.3) .49
o.01 240 (220–278) 260 (240–308) o.01
o.01 240 (205–260) 260 (240–280) o.01
1.00 15 (0–40) 10 (0–35) .25
.25 39 (37–46) 43 (38–46) .43
.75 47 (38–52) 46 (41–54) .09
.21 85 (79–90) 89 (80–97) .21
.17 84 (71–87) 83 (73–90) .27
o.01 12/12 (100) 6/12 (50) o.01
o.01 5.5 (2.3–11.0) 1.5 (0.0–6.5) o.01
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pulmonary veins, the atria, and the vein of Marshal.2 On the
contrary, continuous low level vagus nerve stimulation
suppresses AF inducibility by directly suppressing the neural
activity of major ganglionated plexi within intrinsic cardiac
autonomic nervous system and sympathetic nerve activ-
ity.27,28 Bilateral stellectomy signiﬁcantly decreases the
incidence of electrically induced AF and facilitates sinus
rhythm maintenance.29 Unilateral stellate ganglionectomy
can reduce AF initiation and prevent electrical remodeling in
the atrium and pulmonary veins.4
In accordance to these experimental reports, we observed
a signiﬁcant decrease in AF inducibility after unilateral SGB,
while in patients with still inducible AF, the duration of the
arrhythmia was signiﬁcantly shorter. The suppressed sym-
pathetic activity and downregulated β1-adrenergic receptors
have been proposed as mechanisms contributing to this
beneﬁcial effect.19,23,29 Vagal stimulation associated with an
altered release of neuromodulators (such as serotonin and
norepinephrine), as well as nitric oxide, which is coupled to
the signaling pathways of multiple neuropeptides and ion
channels, may also play a role.30–32
In addition, our observations are in concordance with
those of Stavrakis et al33 after low-level transcutaneous vagal
stimulation in 40 patients with paroxysmal AF: atrial ERP
prolongation was associated with shorter AF duration with-
out a signiﬁcant decrease in heart rate. It is noteworthy that
this technique lasted 1 hour and was not discomfort-free for
patients.
Clinical implications
The beneﬁcial effect of SBG on atria may have a clinical
impact on patients with paroxysmal AF and could be studied
as an adjunctive treatment to terminate or prevent the
arrhythmia. This technique could be performed and eval-
uated before cardioversion as a mean to facilitate sinus
rhythm restoration. Furthermore, repeated temporary SGB
could be applied after cardiac surgery and might be proven
helpful in preventing postoperational AF occurrence, prob-
ably with a mechanism similar to that of repetitive temporary
sphenopalatine ganglion block for the acute treatment of
migraine.34 Current clinical attempts to apply reversible SGB
via implantable neurostimulators are worth further inves-
tigation and support.35
Study limitations
The study protocol and, subsequently, the assessment of
atrial electrophysiological properties were adapted to the PVI
procedure. Therefore, a more detailed estimation of ERP and
conduction time in multiple areas in each atrium was beyond
the study design. The use of multipolar catheters in the atria
could facilitate a more dense evaluation of changes in atrial
electrophysiological properties after SBG.
The limited number of the studied patients might have
obscured changes in intra- or interatrial conduction, although
from a statistical point of view this sample was poweredenough for pairwise comparisons of these continuous param-
eters. In addition, the studied population was larger or
comparable to that of other published clinical studies. 6,23,33
In any case, our observations, along with previous evidence,
could be the starting point for more extensive clinical studies
of the impact of SBG on atrial arrhythmias.Conclusion
In patients with paroxysmal AF, unilateral temporary SGB is
associated with atrial ERP prolongation, without a signiﬁcant
increase in intra- and interatrial conduction time. This effect
has a beneﬁcial impact on atria, in terms of reducing AF
inducibility and duration. Right and left SGB seems to be
equivalent in their antiarrhythmic result. The clinical sig-
niﬁcance of these observations deserves further investigation
into the prevention of AF development and recurrence or in
sinus rhythm restoration after an episode of arrhythmia.References
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